首页|期刊导航|西南医科大学学报|宫颈腺癌的分子遗传特征及其诊断与治疗策略

宫颈腺癌的分子遗传特征及其诊断与治疗策略OA

Molecular Genetic Features,Diagnosis,and Treatment Strategies of Endocervical Adenocarcinoma

中文摘要英文摘要

宫颈腺癌因其分子遗传学特征的独特性和临床表现异质性受到广泛关注.从病因学上分为人乳头瘤病毒(HPV)相关型与HPV非相关型,二者突变谱和分子机制存在显著差异,诊断与治疗策略有所不同.分子病理学与基因组学的进展加深了我们对宫颈腺癌遗传基础的认识,本文围绕宫颈腺癌的分子遗传学特征展开系统阐述,结合现行诊断标准和分类体系的新进展,探讨传统手术、放化疗与分子靶向治疗及免疫治疗策略的优势与局限,并提出基于分子靶点和免疫调节的新兴治疗方法的趋势,以期为临床实践提供参考,助力提升宫颈腺癌的诊疗水平.

Cervical adenocarcinoma,a clinically significant subtype of cervical cancer,has drawn growing research attention because of its distinct molecular genetic landscape and heterogeneous clinical presentations.From an etiological perspective,it falls into two main subtypes:human papillomavirus(HPV)-associated and HPV-independent adenocarcinomas.These two subtypes differ markedly in their mutational profiles and underlying molecular mechanisms,which in turn influences diagnostic approaches and thera-peutic outcomes.Recent advances in molecular pathology and genomics have improved our understanding of the genetic basis of cervi-cal adenocarcinoma,providing a foundation for precision diagnostics and personalized treatment.This review systematically summa-rizes the molecular genetic characteristics of cervical adenocarcinoma.Informed by the latest developments in diagnostic standards and classification systems,this review explores the strengths and limitations of conventional surgery,chemoradiotherapy,as well as molecular targeted and immunotherapeutic strategies.Furthermore,it discusses emerging therapeutic trends based on molecular targets and immune modulation,providing a reference for clinical practice and contributing to the improvement of diagnosis and treatment of cervical adenocarcinoma.

余新颖;周新惠

浙江大学医学院附属第一医院 妇科(杭州 310000)浙江大学医学院附属第一医院 妇科(杭州 310000)

医药卫生

宫颈腺癌分子遗传学人乳头瘤病毒胃型腺癌

Cervical adenocarcinomaMolecular geneticshuman papillomavirus(HPV)gastric-type adenocarcinoma

《西南医科大学学报》 2026 (5)

565-569,5

10.3969/j.issn.2096-3351.2026.05.003

评论